Pathik Gandotra of Dron Capital feels Ranbaxy Labs can also give a very high return, but it is extremely risky, he adds.
first published: Oct 5, 2013 03:24 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.